Basit öğe kaydını göster

dc.contributor.authorBAYRAM, FAHRİ
dc.contributor.authorERDEM, YUNUS
dc.contributor.authorOzin, Bulent
dc.contributor.authorŞAHİN, İBRAHİM
dc.contributor.authorERTÜRK, ŞEHSUVAR
dc.contributor.authorBitigen, Atila
dc.contributor.authorTokgozoglu, Lale
dc.contributor.authorGuler, Kerim
dc.contributor.authorTukek, Tufan
dc.contributor.authorAydogdu, Sinan
dc.contributor.authorALTUN, BÜLENT
dc.contributor.authorDERİCİ, ÜLVER
dc.contributor.authorABACI, ADNAN
dc.contributor.authorSABUNCU, TEVFİK
dc.contributor.authorARICI, MUSTAFA
dc.date.accessioned2021-03-05T18:51:07Z
dc.date.available2021-03-05T18:51:07Z
dc.date.issued2019
dc.identifier.citationAydogdu S., Guler K., BAYRAM F., ALTUN B., DERİCİ Ü., ABACI A., Tukek T., SABUNCU T., ARICI M., ERDEM Y., et al., "2019 Turkish Hypertension Consensus Report", TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.47, ss.535-546, 2019
dc.identifier.otherav_cc5ec2bc-6602-4a6c-b6dc-39ca20764e20
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/135305
dc.identifier.urihttps://doi.org/10.5543/tkda.2019.62565
dc.description.abstractThe Turkish Hypertension Consensus Report was prepared for the first time in 2015 to adapt the European and American international guidelines to our clinical practice and to create a practical report that could be a basic reference for all physicians dealing with hypertensive patients. This report, which was prepared by a committee with representation from 5 leading hypertension associations, has been accepted and is widely used. New clinical studies in hypertension literature and updated international guidelines since 2015 have demanded an update of the Turkish Hypertension Consensus Report as well. In this updated 2019 report, blood pressure levels were classified as Normal, Elevated, Stage 1, and Stage 2 hypertension. A new section was added for secondary hypertension. It was specified that drug treatment may be initiated with any 1 or a combination of 4 groups of drugs (diuretics, calcium channel blockers, angiotensin-converting enzyme [ACE] inhibitors, and angiotensin receptor blockers [ARBs]), except a combination of an ACE inhibitor and an ARB. It was emphasized that beta-blockers may be a first choice for hypertension treatment in diseases such as atrial fibrillation, heart failure, and coronary artery disease. The initial recommendation for hypertension treatment is a combination therapy in patients with a blood pressure level >= 150/90 mmHg. Target blood pressure values were redefined according to age and the presence of comorbidities. The hypertension treatment algorithm was renewed; it is proposed that drug therapy can also be initiated with a risk-based approach for the group with an elevated blood pressure (systolic blood pressure: 120-139 mmHg, diastolic blood pressure: 80-89 mmHg). The threshold clinic systolic blood pressure level was reduced from 160 mmHg to >= 150 mmHg for the initiation of drug therapy in individuals 80 years of age or more. The section on the treatment of special groups has now been expanded to include pregnancy and lactation. As in the previous report, in this update, practical recommendations for the most common cases seen in the clinic were the goal, rather than a comprehensive report that addresses all aspects of hypertension. This report has evidence-based recommendations for most patients; however, it should be kept in mind that there may be differences from 1 patient to another and that physicians should take an individualized approach according to a good clinical evaluation.
dc.language.isoeng
dc.subjectKardiyoloji
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.title2019 Turkish Hypertension Consensus Report
dc.typeMakale
dc.relation.journalTURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
dc.contributor.departmentTurkiye Yuksek Ihtisas Egitim & Arastirma Hastans , ,
dc.identifier.volume47
dc.identifier.issue6
dc.identifier.startpage535
dc.identifier.endpage546
dc.contributor.firstauthorID267809


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster